Category Archives: Noticias

Johnson & Johnson SEQT Prize – Marta Durán

Marta Durán Martínez won Johnson & Johnson Prize of Sociedad Española de Química Terapéutica (SEQT) para Investigadores Noveles en el Campo de la Búsqueda y desarrollo de Nuevos Fármacos. Congratulations!

The award was received during the 19th Meeting of the Spanish Society of Medicinal Chemistry, Vitoria.
Flash communication:
Unveiling the therapeutic potential of the integrin-linked kinase with small molecules

Chem. Sci. 2025

Visible-light-initiated metal-free Csp3–Csp3 to Csp3–N conversion in homobenzylic sulfonamides with N-iodoimides

Guillermo Morales-Ortega,   Estíbaliz Merino  and  Javier Carreras*

We report a simple protocol for the transformation of Csp3–Csp3 to Csp3–N in homobenzylic sulfonamides in combination with N-iodoimides to form gem-diamino derivatives. The reaction exhibits a wide functional group tolerance and allows the incorporation of bioactive-derived fragments. The mechanistic insights provided by control experiments and DFT calculations suggest that an imine intermediate is formed after C−C bond cleavage.

Chem. Sci. 2025
DOI: 10.1039/D5SC02168E

Adv. Synth. Cat. 2025

Synthesis of Polysubstituted Naphthalenes via Metal-Free Borylative Cyclization of o-Alkynylstyrenes

Marcos Humanes, Manuel A. Fernández-Rodríguez,* Patricia García-García*

A selective, metal-free method for the synthesis of boron-functionalized polysubstituted naphthalenes via BCl3-mediated cyclization of α-substituted o-alkynylstyrenes is described. The reaction exhibits broad substrate scope, tolerating various groups such as ethers, sulfides and halogens, and delivers high yields under mild conditions, even at gram scale. The resulting Bpin-functionalized naphthalenes serve as versatile building blocks, facilitating further transformations of the C−B bond into C−H, C−C, C−I, C−O, and C−N bonds, thereby increasing molecular complexity and enabling the design of more functionalized products. Notably, this sustainable and straightforward protocol selectively introduces the Bpin group at the sterically hindered α-carbon of the naphthalene framework, complementing C–H borylations of the naphthalene core, that preferentially occur at the β-position. As a result, the developed approach significantly broadens the accessibility of B-functionalized naphthalene derivatives for synthetic and application-oriented purposes.

Adv. Synth. Cat. 2025
DOI: 10.1002/adsc.202500244

Patent 2025

Ligandos moduladores de la quinasa ligada a integrinas y uso de los mismos para el tratamiento de enfermedades

Marta Durán, Juan José Vaquero, Mercedes Griera, Sergio de Frutos, Diego Rodríguez Puyol, Javier García Marín*

La presente invención se refiere a nuevos compuestos que actúan como ligandos de la quinasa ligada a integrinas (del inglés ILK), facilitando la polimerización del citoesqueleto de actina y favoreciendo así el tráfico de receptores celulares desde los compartimentos intracelulares a la superficie de las células. Por este motivo, pueden ser utilizados en enfermedades como la diabetes mellitus tipo 2 o la diabetes insípida nefrogénica y, por extensión, en cualquier enfermedad en la que las alteraciones fisiopatológicas sean debidas, total o parcialmente, a un transporte transmembrana disminuido como las tubulopatías renales originadas por una pérdida de transportadores.

No: P202530222 (14/03/2025)